Your browser is no longer supported. Please, upgrade your browser.
Settings
CLSN Celsion Corporation daily Stock Chart
CLSN [NASD]
Celsion Corporation
Index- P/E- EPS (ttm)-2.06 Insider Own0.40% Shs Outstand18.24M Perf Week24.03%
Market Cap58.37M Forward P/E- EPS next Y-1.23 Insider Trans101.59% Shs Float17.50M Perf Month21.21%
Income-20.10M PEG- EPS next Q-0.27 Inst Own11.30% Short Float6.26% Perf Quarter25.98%
Sales0.50M P/S116.74 EPS this Y77.10% Inst Trans-20.94% Short Ratio4.93 Perf Half Y18.52%
Book/sh1.34 P/B2.39 EPS next Y-10.80% ROA-54.50% Target Price9.00 Perf Year39.74%
Cash/sh1.13 P/C2.82 EPS next 5Y- ROE-128.90% 52W Range1.24 - 6.06 Perf YTD19.40%
Dividend- P/FCF- EPS past 5Y43.70% ROI-76.20% 52W High-47.19% Beta1.30
Dividend %- Quick Ratio3.70 Sales past 5Y- Gross Margin- 52W Low158.06% ATR0.17
Employees19 Current Ratio3.70 Sales Q/Q0.00% Oper. Margin- RSI (14)72.34 Volatility10.88% 5.54%
OptionableYes Debt/Eq0.00 EPS Q/Q85.10% Profit Margin- Rel Volume4.92 Prev Close3.32
ShortableYes LT Debt/Eq0.00 EarningsMay 11 BMO Payout- Avg Volume222.33K Price3.20
Recom1.00 SMA2021.68% SMA5028.73% SMA20028.19% Volume1,093,868 Change-3.61%
Oct-04-17Upgrade Maxim Group Hold → Buy $7
Apr-10-17Resumed Rodman & Renshaw Buy $1.50
Nov-10-16Downgrade Maxim Group Buy → Hold
Jul-12-16Resumed H.C. Wainwright Buy $3
Jan-19-16Reiterated Maxim Group Buy $12 → $9
Jul-15-15Initiated Maxim Group Buy $12
Jan-10-14Resumed HC Wainwright Buy $5 → $8
Aug-16-12Reiterated Griffin Securities Buy $10 → $18
Feb-16-12Initiated Brean Murray Buy $7
Oct-26-11Initiated Rodman & Renshaw Mkt Outperform $6
Nov-11-09Initiated Needham Buy $7
Jun-20-18 08:00AM  Today's Research Reports on Trending Tickers: Celsion and Spark Therapeutics ACCESSWIRE
Jun-06-18 02:10PM  Celsion Corporation (NASDAQ:CLSN): Has Recent Earnings Growth Beaten Long-Term Trend? Simply Wall St.
May-28-18 12:02PM  Best NasdaqGS Growth Companies Simply Wall St.
May-16-18 03:52AM  Edited Transcript of CLSN earnings conference call or presentation 11-May-18 3:00pm GMT Thomson Reuters StreetEvents
May-15-18 07:30AM  Analysis: Positioning to Benefit within United Natural Foods, Capitol Federal Financial, Royal Gold, Celsion, National CineMedia, and Nu Skin Enterprises Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
May-11-18 08:00AM  Celsion Corporation Reports First Quarter 2018 Financial Results and Provides Business Update GlobeNewswire
May-08-18 08:00AM  Celsion Corporation to Present at the RHK Capital 2018 Disruptive Growth and Healthcare Conference GlobeNewswire
May-04-18 09:00AM  Celsion Corporation to Hold First Quarter 2018 Financial Results Conference Call on Friday, May 11, 2018 GlobeNewswire
Apr-20-18 07:00AM  Free Post Earnings Research Report: Egalet's Q4 Top-Line Growth Beat Estimates ACCESSWIRE
Apr-12-18 08:00AM  International Liver Congress 2018 Symposium Highlights Celsions ThermoDox® in Treatment of Primary Liver Cancer GlobeNewswire
Apr-09-18 08:30AM  Data Monitoring Committee (DMC) Completes Planned Safety and Data Review of Celsions Phase III OPTIMA Study of ThermoDox® in Primary Liver Cancer GlobeNewswire
Mar-27-18 07:16PM  Edited Transcript of CLSN earnings conference call or presentation 27-Mar-18 3:00pm GMT Thomson Reuters StreetEvents
08:30AM  Celsion Corporation Reports Fourth Quarter and Full-Year 2017 Financial Results GlobeNewswire
08:00AM  Celsion Corporation to Host Earnings Call ACCESSWIRE
07:18AM  When Will Celsion Corporation (NASDAQ:CLSN) Become Profitable? Simply Wall St.
Mar-20-18 08:30AM  Celsion Corporation to Hold Year-End 2017 Financial Results Conference Call on Tuesday, March 27, 2018 GlobeNewswire
Mar-12-18 08:00AM  Celsion Corporation to Present at Upcoming Investor Conferences GlobeNewswire
Mar-08-18 08:30AM  New Research Coverage Highlights Gastar Exploration, CENTENNIAL RES, Advance Auto Parts, Celsion, Regions Financial, and Abraxas Petroleum Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Mar-05-18 10:15AM  Celsion Announces Ovarian Cancer Expert Presentation at Oppenheimer & Co. Investor Event GlobeNewswire +8.89%
Feb-12-18 08:30AM  Celsion Announces ThermoDox® HEAT Study Presentation at Korean Liver Cancer Associations 12th Annual Scientific Meeting GlobeNewswire
Jan-18-18 08:00AM  Celsion Corporation Provides Corporate Update and 2018 Outlook GlobeNewswire
Jan-05-18 09:42AM  Celsion's Phase I/II Cancer Study Initiation Gets FDA Nod Zacks
Jan-04-18 03:37PM  FDA Win Sends Celsion Corporation (CLSN) Shares Higher InvestorPlace
08:52AM  Zacks.com highlights: Hecla Mining, Cloud Peak Energy, Celsion, QuickLogic and Precision Drilling Zacks
08:49AM  Celsion Corporation (CLSN) Shares on the Rise; Heres Why SmarterAnalyst
08:37AM  Celsion shares rise 20% after FDA clears its ovarian cancer therapy for a phase 1/2 trial MarketWatch
08:00AM  Celsion Announces FDA Clearance of the OVATION II Study for the Evaluation of GEN-1 Immunotherapy to Treat Newly Diagnosed Stage III/IV Ovarian Cancer GlobeNewswire
Jan-03-18 09:07AM  5 Breakout Stocks Offering Terrific Returns Zacks
Jan-02-18 11:04AM  ETFs with exposure to Celsion Corp. : January 2, 2018 Capital Cube +5.22%
Dec-22-17 11:35AM  ETFs with exposure to Celsion Corp. : December 22, 2017 Capital Cube
Dec-11-17 01:41PM  ETFs with exposure to Celsion Corp. : December 11, 2017 Capital Cube -7.69%
Nov-30-17 01:38PM  ETFs with exposure to Celsion Corp. : November 30, 2017 Capital Cube -7.85%
Nov-29-17 08:04AM  Celsion Corp. :CLSN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017 Capital Cube
Nov-27-17 08:25AM  Recent Analysis Shows Amazon, Oracle, Whiting Petroleum, Mondelez International, Synergy Resources, and Celsion Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire -6.13%
Nov-21-17 08:29AM  Heres Why Celsion Corporation Draws a Vote of Confidence from Oppenheimer SmarterAnalyst +33.64%
Nov-20-17 05:18PM  7 Stock's Moving In Monday's After-Hours Session Benzinga +7.00%
09:30AM  Celsion Corporation (CLSN) Shares Climb on Back of New Findings in Liver Tumours Study SmarterAnalyst
08:00AM  Celsion Announces Publication of the Study of ThermoDox® + Ultrasound, TARDOX Study Protocol in the Journal of Therapeutic Ultrasound GlobeNewswire
Nov-14-17 04:46PM  Edited Transcript of CLSN earnings conference call or presentation 14-Nov-17 4:00pm GMT Thomson Reuters StreetEvents -5.19%
03:29PM  Is It The Right Time To Buy Celsion Corporation (CLSN)? Simply Wall St.
08:10AM  Todays Research Reports on Stocks to Watch: Celsion Corporation and Nektar Therapeutics ACCESSWIRE
08:00AM  Celsion Corporation Reports Third Quarter 2017 Financial Results and Provides Business Update GlobeNewswire
07:20AM  Celsion Corporation to Host Earnings Call ACCESSWIRE
Nov-13-17 07:23PM  CORRECTING and REPLACING -- Celsion Files Immunotherapy Clinical Protocol for the Evaluation of GEN-1 to Treat Newly Diagnosed Ovarian Cancer GlobeNewswire +6.00%
05:15PM  Celsion Files Immunotherapy Clinical Protocol for the Evaluation of GEN-1 to Treat Newly Diagnosed Ovarian Cancer GlobeNewswire
Nov-07-17 10:00AM  ETFs with exposure to Celsion Corp. : November 7, 2017 Capital Cube
09:00AM  Celsion Corporation to Hold Third Quarter 2017 Financial Results Conference Call on Tuesday, November 14, 2017 GlobeNewswire
Oct-27-17 09:46AM  Celsion Corporation (CLSN) Spooks Investors with a Share Dilution SmarterAnalyst -19.23%
09:10AM  Celsion Corporation Announces Pricing of Underwritten Offering of Common Stock and Warrants to Purchase Common Stock GlobeNewswire
Oct-18-17 08:30AM  Celsion Provides Summary of Research and Development Day Held on October 12, 2017 GlobeNewswire
07:30AM  This Unknown E-Commerce Stock Could Return 300% in 2017 ACCESSWIRE
Oct-17-17 08:30AM  Celsion Provides Summary of Research and Development Day Held on Thursday, October 12, 2017 GlobeNewswire -6.13%
Oct-16-17 08:30AM  Celsion Announces Publication of the HEAT Study Manuscript in the High Impact Journal, Clinical Cancer Research GlobeNewswire
Oct-12-17 11:03AM  Celsion to Host Research and Development (R&D) Day on Thursday, October 12, 2017 GlobeNewswire -11.82%
Oct-10-17 11:11AM  ETFs with exposure to Celsion Corp. : October 10, 2017 Capital Cube +23.66%
Oct-09-17 10:13AM  Cancer Space Last Week Update: Pipeline Expansion in Focus Zacks +11.04%
Oct-04-17 01:45PM  Celsion Corporation Announces Gross Proceeds of $15.6 Million from the Exercise of Existing Common Stock Warrants GlobeNewswire -37.29%
12:24PM  Celsion's Immunotherapy Candidate Impresses, Stock Surges Zacks
09:00AM  Celsion to Host Research and Development Update October 12, 2017 GlobeNewswire
08:35AM  Updated Outlook and Pipeline Review on Celsion Corporation ACCESSWIRE
08:20AM  Today's Research Reports on Stocks to Watch: Celsion Corporation and Cesca Therapeutics ACCESSWIRE
Oct-03-17 09:00AM  Celsion Announces Final Clinical and Translational Research Data from its OVATION Study at the AACR Special Conference on Ovarian Cancer GlobeNewswire +301.32%
Sep-27-17 09:00AM  Celsion Provides Update on ThermoDox® in the Phase III OPTIMA Study of Primary Liver Cancer GlobeNewswire
Sep-18-17 05:35PM  ETFs with exposure to Celsion Corp. : September 18, 2017 Capital Cube +9.09%
Sep-08-17 08:57AM  Stocks Near 52-Week Lows: 4 Attractive Picks Zacks
Aug-31-17 05:46PM  ETFs with exposure to Celsion Corp. : August 31, 2017 Capital Cube
Aug-24-17 10:47AM  Celsion Corp. :CLSN-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017 Capital Cube
09:30AM  Celsion Announces Presentation of OVATION Study Findings at the Upcoming AACR Special Conference GlobeNewswire
Aug-18-17 02:15PM  Edited Transcript of CLSN earnings conference call or presentation 15-Aug-17 3:00pm GMT Thomson Reuters StreetEvents
Aug-15-17 08:00AM  Celsion Corporation Reports Second Quarter 2017 Financial Results and Provides Business Update GlobeNewswire
07:40AM  Investor Network: Celsion Corporation to Host Earnings Call ACCESSWIRE
Aug-08-17 09:00AM  Celsion Corporation to Hold Second Quarter 2017 Financial Results Conference Call on Tuesday, August 15, 2017 GlobeNewswire
Aug-07-17 08:00AM  Data Monitoring Committee Completes Mid-Study Review of Celsions Phase III ThermoDox® OPTIMA Study in Primary Liver Cancer GlobeNewswire -12.26%
Aug-04-17 06:35PM  Celsion Corporation to Delist from the Tel Aviv Stock Exchange GlobeNewswire
Aug-02-17 08:00AM  Celsion Announces Latest Translational Data from the OVATION Study in Newly Diagnosed Advanced Ovarian Cancer Patients GlobeNewswire
Jul-07-17 08:00AM  Today's Research Reports on Stocks to Watch: Valeant Pharmaceuticals and Celsion Corporation Accesswire
Jul-06-17 02:15PM  Celsion Completes Ovarian Cancer Trial Enrollment, Stock Up Zacks -20.66%
09:15AM  Celsion Corporation Announces $5 Million Registered Direct Offering GlobeNewswire
Jul-05-17 10:37AM  This Biotech Stock Is Surging More Than 20% Today TheStreet.com +19.80%
08:00AM  Celsion Announces Completion of OVATION Study and Provides Update on its Immunotherapy Trial in Advanced Stage III and IV Ovarian Cancer GlobeNewswire
Jun-22-17 03:00PM  Celsion Corporation Announces Cancellation of Registered Direct Offering GlobeNewswire +8.68%
Jun-19-17 03:05PM  ETFs with exposure to Celsion Corp. : June 19, 2017 Capital Cube -23.75%
09:15AM  Celsion Corporation Announces $5.4 Million Registered Direct Offering GlobeNewswire
Jun-16-17 07:04AM  Celsion's stock rockets after withdrawing stock offering MarketWatch +56.10%
Jun-14-17 08:00AM  Celsion Corporation Regains Compliance with NASDAQ Listing Requirements GlobeNewswire
Jun-08-17 08:30AM  Celsion Encouraging Ovation Study Results, Pipeline Review and Market Potential Accesswire +7.00%
Jun-05-17 10:15AM  UPDATE: Celsion shares surge 74% on news of positive trial of ovarian cancer treatment MarketWatch +24.06%
09:43AM  Stocks to Watch: Apple, Snap, Herbalife The Wall Street Journal
08:00AM  Celsion Announces Presentation of OVATION Study Findings at the ASCO 2017 Annual Meeting GlobeNewswire
May-30-17 12:21PM  ETFs with exposure to Celsion Corp. : May 30, 2017 Capital Cube -16.40%
May-26-17 04:05PM  Celsion Corporation Announces Stock Consolidation GlobeNewswire
09:39AM  Celsion Corp. :CLSN-US: Earnings Analysis: Q1, 2017 By the Numbers : May 26, 2017 Capital Cube
May-20-17 01:06PM  Edited Transcript of CLSN earnings conference call or presentation 12-May-17 3:00pm GMT Thomson Reuters StreetEvents
May-12-17 09:00AM  Investor Network: Celsion Corporation to Host Earnings Call Accesswire
08:00AM  Celsion Corporation Reports First Quarter 2017 Financial Results and Provides Business Update GlobeNewswire
May-05-17 08:00AM  Celsion Corporation to Hold First Quarter 2017 Financial Results Conference Call on Friday, May 12, 2017 GlobeNewswire
May-04-17 08:00AM  Celsion Updates Clinical Data from the OVATION Study in Newly Diagnosed  Advanced Ovarian Cancer Patients GlobeNewswire
Apr-27-17 03:51PM  ETFs with exposure to Celsion Corp. : April 27, 2017 Capital Cube
Apr-20-17 08:30AM  Celsion Announces Presentation of OVATION Study Findings at the Upcoming ASCO 2017 Annual Meeting GlobeNewswire +6.41%
Apr-17-17 12:50PM  ETFs with exposure to Celsion Corp. : April 17, 2017 Capital Cube
Celsion Corporation, a development stage oncology drug company, focuses on the development and commercialization of directed chemotherapy, DNA-mediated immunotherapy, and RNA based therapy products for the treatment of cancer. The company's lead product includes ThermoDox, a liposomal encapsulation of doxorubicin that is in Phase III clinical trials for primary liver cancer; and under Phase II clinical trials to treat recurrent chest wall breast cancer. It is also developing GEN-1, a DNA-based immunotherapeutic product for the localized treatment of ovarian and brain cancers. Celsion Corporation was founded in 1982 and is headquartered in Lawrenceville, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tardugno Michael HChairman, President and CEOApr 09Buy2.302,5005,75020,200Apr 09 01:14 PM
Tardugno Michael HChairman, President and CEOMar 05Buy2.387,50017,84017,700Mar 05 11:24 AM
Martinez Alberto R JrDirectorFeb 22Buy2.177,14315,50020,000Feb 22 12:09 PM
Fritz Frederick J.DirectorFeb 20Buy2.173,0006,5109,500Feb 21 09:27 AM
Fritz Frederick J.DirectorFeb 20Buy2.173,0006,51012,841Feb 21 09:27 AM
Hooper Robert WDirectorFeb 20Buy2.1813,62529,70315,687Mar 02 04:40 PM
Fritz Frederick J.DirectorJul 07Buy1.906,50012,3506,500Jul 07 04:44 PM
Fritz Frederick J.DirectorJul 07Buy1.886,50012,2209,841Jul 07 04:44 PM